http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9210206-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c3a6a8d3a6fc4dd10d775586b7cacc82 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-57 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-57 |
| filingDate | 1991-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9dc6550277242a112755457a7b141a5a |
| publicationDate | 1992-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-9210206-A1 |
| titleOfInvention | Use of plasminogen activator inhibitor type 2 in the treatment of cancer |
| abstract | PAI-2 (placental-type plasminogen activator inhibitor; plasminogen activator inhibitor type 2; minactivin) may be used at low doses to combat cancers, especially peritoneal cancers. It may be administered via an implanted depot or delivery device for controlled release. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6616984-B1 |
| priorityDate | 1990-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 64.